Cleary Gottlieb Steen & Hamilton, Freshfields Bruckhaus Deringer, and Hogan Lovells have helped secure a €500 million round of financing for one of the biggest “unicorns” in French tech and tele-healthcare.
Doctolib, a start-up online medical reservations service, completed a Series G financing round of equity and debt led by the investment funds Eurazeo, BPIfrance, Accel, and General Atlantic.
The round values Doctolib at €5.8 billion should it go public. The potential valuation qualifies the company as a unicorn—Wall Street slang for a new business that is valued at more than $1 billion and is privately owned, and therefore is viewed as offering exceptional potential for investors.
Doctolib, which is based in Paris and has operations in France and Germany, was founded in 2013. Originally used by patients and physicians to book routine appointments, the service took off during the COVID-19 pandemic when it became the go-to platform for booking vaccinations and tests. It now also offers telehealth consultations.
The company plans to double its workforce in five years and add new services, according to a statement announcing the round.
Cleary advised Doctolib, fielding a team led by corporate partner Marie-Laurence Tibi and including counsel Jeanne Theuret.
Freshfields advised General Atlantic with a team led by corporate/M&A and private equity partner Julien Rebibo.
Hogan Lovells advised Eurazeo, BPIfrance and Accel, fielding a team led by partners Matthieu Grollmund and Hélène Parent on corporate; Mikael Salmela and Patrice Navarro on IP, IT, and regulatory and medical; and Eric Paroche on competition, and including counsel Pierre-Marie Boya.